GlaxoSmithKline Reports Higher Sales

GlaxoSmithKline reported climbing sales but lower profits in the third quarter of 2015, as it continued its shift to a higher-volume, lower-margin business following its $20 billion asset swap deal with Novartis.

Popular Posts


EOF

(Visited 5 times, 1 visits today)

Vote on this story -->>>


this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami